Transvesical Prostate Adenomectomy in Mbujimayi: Frequency, Clinical Presentation, and Postoperative Outcomes.

Authors

  • Edmond Issa Kanda Banema Official University of Mbujimayi, Mbujimayi, DRC
  • Trésor Kabuya Kabamba Official University of Mbujimayi, Mbujimayi, DRC
  • Séraphin Binene Katulondi Official University of Mbujimayi, Mbujimayi, DRC
  • Joseph Luboya Kabila Official University of Mbujimayi, Mbujimayi, DRC
  • Pierre Tangila Tangila Official University of Mbujimayi, Mbujimayi, DRC
  • Delphin Kayembe Makubakuba Official University of Mbujimayi, Mbujimayi, DRC
  • Alidor Mbangila Yombo Official University of Mbujimayi, Mbujimayi, DRC
  • Clément Kadima Mutombo Official University of Mbujimayi, Mbujimayi, DRC
  • Matthieu Loposso Nkumu University of Kinshasa, Kinshasa, DRC.
  • Séverin Uwonda Akinja Official University of Mbujimayi, Mbujimayi, DRC
  • Joseph Ngandu Tshilunda Official University of Mbujimayi, Mbujimayi, DRC

DOI:

https://doi.org/10.47941/ijhs.3755

Keywords:

Transvesical Prostate Adenomectomy, Frequency, Clinic, Postoperative Outcomes, Mbujimayi.

Abstract

Purpose: Transvesical prostate adenomectomy remains a relevant option in low-resource settings despite the growing availability of minimally invasive techniques. This study aimed to assess the current practice of this procedure in Mbujimayi.

Methods: This descriptive, retrospective, multicenter study included 85 patients who underwent transvesical prostate adenomectomy between January 1, 2019, and December 31, 2024.

Results: The frequency of transvesical prostate adenomectomy was 15.2%. The mean age of the patients was 69.5± 7.1years. Most patients presented late, often after resorting to traditional treatment (69.8%), and chronic urinary retention was the main reason for consultation (56.5%). A three-way transurethral catheter alone was the most commonly used intraoperative device. The mean operative time was 69.1 ± 20.7minutes, and all patients received transfusions. Early postoperative complications were frequent (50.6%); mainly deep surgical site infections associated with vesicocutaneous fistulas (30.2%). The mean postoperative stay was 20.2 ± 12.4 days. The outcome was favorable in 96.5% of cases, and the mortality rate was 3.5%.

Conclusion: Transvesical prostatectomy is commonly performed in our setting, particularly in elderly patients who present late with chronic urinary retention. Despite the high rate of postoperative morbidity, the overall outcome remains satisfactory.

Unique contribution to theory, practice and health policy:  This study provides the first local data on transvesical prostate adenomectomy and offers key insights to improve perioperative care and guide health policy in resource‑limited settings such as Mbujimayi.

Downloads

Download data is not yet available.

Author Biographies

Edmond Issa Kanda Banema, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

Trésor Kabuya Kabamba, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

Séraphin Binene Katulondi, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

Joseph Luboya Kabila, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

Pierre Tangila Tangila, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

Delphin Kayembe Makubakuba, Official University of Mbujimayi, Mbujimayi, DRC

Department of Gynecology and Obstetrics

Alidor Mbangila Yombo, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

Clément Kadima Mutombo, Official University of Mbujimayi, Mbujimayi, DRC

Department of Gynecology and Obstetrics

Matthieu Loposso Nkumu, University of Kinshasa, Kinshasa, DRC.

Department of Surgery

Séverin Uwonda Akinja, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

Joseph Ngandu Tshilunda, Official University of Mbujimayi, Mbujimayi, DRC

Department of Surgery

References

1. Luhiriri N, Alumeti D, Cirimwami P, Ahuka O. Prise en charge diagnostique et chirurgicale de l’hypertrophie bénigne de la prostate à l’hôpital de panzi – république démocratique du congo. Uro’Andro.2016 ; 1(6): 289-93.

2. Abbou C, Salomon L, Chopin D, Hallot O. Approche actuelle de la prise en charge de l’HBP. Ann Urol.1996 ; 30: 294-310.

3. Agence Nationale d’Accréditation et d’Evaluation en Santé (Anaes). Prise en charge diagnostique et thérapeutique de l’HBP. Anaes. 2003 ; 4.

4. Chartier E. Urologie. 4ème Edition, Collection Med-line. 2002.

5. Botcho G, Kpatcha T, Tengue K, Dossouvi T, Sewa E, Simlawo K et al. Morbidité et mortalité après adénomectomies prostatiques par voie transvésicale au Centre hospitalier universitaire de Kara. African journal of Urology.2018 ; 24 : 353-8 DOI:10.1016/j.afju.2018.01.008

6. Descazeaud A, Robert G, De La Taille A. Management of the bladder outlet obstruction associated with BPH in patients with special circumstances and/ou complications. Prog Urol.2018 ; 28 : 868-74. Doi: https://doi.org/10.1016/j.purol.2018.08.006

7. Descazeaud A, Robert G, Delongchamps N, Cornu J, Saussine C, SHaillot O, et al. Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association. Prog Urol.2012; 22: 977-88.

8. Holtgrewe L. Transurethral Prostatectomy. Urologic Clinics of North America.1995; 22:357–68.

9. Parsons J, Rangarajan S, Palazzi K, Chang D. A National, Comparative Analysis of Perioperative Outcomes of Open and Minimally Invasive Simple Prostatectomy. Journal of Endourology. 2015;29:919–24. DOI: 10.1089/end.2014.0879

10. Bah I, Bah M, Barry M, Diallo A, Kante D, Diallo T, et al. Adénomectomie Prostatique Transvésicale : Résultats et Complications au Service d’Urologie Andrologie de l’Hôpital Ignace Deen, CHU de Conakry. Health Sci. Dis.2020 ;9 (21) :55-9. https://doi.org/10.5281/hsd.v21i9.2268

11. Kane R. Ndiaye A, Niang L, Barry M, Labou I, Jolloh M, et al. Résection transurétrale pour hypertrophie bénigne de la prostate au Sénégal. Rev. Afr. Chir. Spéc.2011;5(3) :8–12.

12. Oelke A, Descazeaud A, Emberton M, Gravas S, Michel M, N’Dow J, et al. EAU Guidelines on the Treatment and Follow-Up of Non- Neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. European Urology.2013; 64:118–40. DOI: 10.1016/j.eururo.2013.03.004

13. Mamoulakis C, Trompetter M, Rosette J. Bipolar transurethral resection of the prostate: the ‘golden standard’ reclaims its leading position. Curr. Opin. Urol.2009 ; 19 :26–32. DOI: 10.1097/MOU.0b013e32831e44da

14. Sanni R, Mensah E, Hounnasso P. Complications post-opératoires de l’adénomectomie prostatique transvésicale dans un service de chirurgie générale au Bénin. A propos de 124 cas. Médecine d’Afrique Noire.2015 ; 62 :7.

15. Diallo M, Diallo T, Sow B. Les complications précoces de l’adénomectomie prostatique transvésicale au service d’urologie de Conakry : à propos de 96 cas. Ann. Urol.2001 ; 2(35) :120–4.

16. Diallo M, Konate M, Diakite I, Koumare S, Keita M, Somake A et al. Adénome de la Prostate dans l’Unité de Chirurgie Générale du Centre de Santé de Référence de la Commune VI du District de Bamako : Aspects Cliniques, Paracliniques et Thérapeutiques. Health Sci. Dis.2020 ; 21 :1-4. https://doi.org/10.5281/hsd.v21i5.1978

17. Coulibaly N, Ackoundou C, Nguessan Y, Aye Y, Guei M, Toure D et al. Morbidité et mortalité après adénomectomie prostatique transvésicale au Centre Hospitalier Universitaire de Libreville. A propos de 68 cas. Uro’Andro.2017 ; 1(8) :362-6.

18. Maazou H, Harissou A, Diongolé M, Amadou M. Prise en charge chirurgicale de l’hypertrophie bénigne de la prostate (HBP) : à propos de 123 patients colligés à l’Hôpital National de Zinder. Annales de l’universite Abdou Moumouni de Niamey.2015 ; 19(A-2) : 149-56.

19. Kone S, Samaké B, Keita M, Coulibaly M, Diakité M, Thiero S et al. Prise en charge chirurgicale de l’hypertrophie bénigne de la prostate au service d’urologie de l’hôpital Nianankoro Fomba de Ségou. Jaccr Africa 2022; 6(1): 105-12

20. Adakal O, Rouga M, Abdoulaye B, Amadou H, Maikqssoua M, Mounkeila I et al. Hypertrophie Bénigne de la Prostate au Centre Hospitalier Régional de Maradi:Aspects Cliniques, thérapeutiques et Pronostiaues. Health sciences and disease, 22(11). https://doi.org/10.5281/hsd.v22i11.3089.

21. Mekeme JBM, Fouda JC, Mbouché LO, Mbassi AA, Owon’Abessolo FP, Biyouma M. Hypertrophie bénigne de la prostate: Étude comparative des résultats de la résection transurétrale et de l’adénomectomie. Rév De Méd Et Pharma, 2022;11(2):1218–22. https://www.ajol.info/index.php/rmp/article/view/221992

Downloads

Published

2026-05-29

How to Cite

Banema, E. I. K., Kabamba, T. K., Katulondi, S. B., Kabila, J. L., Tangila, P. T., Makubakuba, D. K., … Tshilunda, J. N. (2026). Transvesical Prostate Adenomectomy in Mbujimayi: Frequency, Clinical Presentation, and Postoperative Outcomes. International Journal of Health Sciences, 9(4), 10–21. https://doi.org/10.47941/ijhs.3755

Issue

Section

Articles